Arreaza L, de la Fuente L, Fernández S, Vázquez J A
Laboratorio de Referencia de Meningococos, Centro Nacional de Microbiología, Instituto de Salud Carlos III, 28220 Majadahonda, Madrid.
Rev Esp Quimioter. 2000 Jun;13(2):182-6.
In the early 1990s a rise in the incidence of meningococcal disease was observed in Galicia, Spain, most cases of which were caused by serogroup C meningococcal strains. As part of the epidemiological analysis of this epidemic wave, two studies of asymptomatic carriers of neisseria meningitidis were carried out: the first took place during the period of maximum incidence and coincided with a massive immunization campaign (December 1996 to January 1997); and the second was conducted one year later (January 1998). A total of 1234 meningococcal strains were isolated in both studies (789 in the first and 445 in the second study) and the susceptibility to rifampin, ciprofloxacin, ceftriaxone and sulfadiazine was determined. The susceptibility to rifampin, ciprofloxacin and cetriaxone was high among the strains isolated in both studies. For sulfadiazine, the percentage of resistant strains was 92.6% for the first and 86.3% for the second study.
20世纪90年代初,西班牙加利西亚地区观察到脑膜炎球菌病发病率上升,其中大多数病例由C群脑膜炎球菌菌株引起。作为此次流行波流行病学分析的一部分,开展了两项关于脑膜炎奈瑟菌无症状携带者的研究:第一项研究在发病率最高期间进行,与大规模免疫运动同时开展(1996年12月至1997年1月);第二项研究在一年后进行(1998年1月)。两项研究共分离出1234株脑膜炎球菌菌株(第一项研究中分离出789株,第二项研究中分离出445株),并测定了这些菌株对利福平、环丙沙星、头孢曲松和磺胺嘧啶的敏感性。在两项研究中分离出的菌株中,对利福平、环丙沙星和头孢曲松的敏感性较高。对于磺胺嘧啶,第一项研究中耐药菌株的百分比为92.6%,第二项研究中为86.3%。